ライフサイエンスコーパス: breakthrough infection

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 sed to low-level replication as the cause of breakthrough infection.

2 an efficacious HIV/AIDS vaccine, even after breakthrough infection.

3 pose to higher acute viremia in the event of breakthrough infections.

4 bly explaining suppressed viremia in vaccine breakthrough infections.

5 ults in improved early disease parameters in breakthrough infections.

6 well as durably control viral replication in breakthrough infections.

7 y of the gamma -spz could explain occasional breakthrough infections.

8 Serological breakthrough infection (7106 mIU/mL) was documented in 1

9 Interestingly, in the RMs showing breakthrough infections, AdC7/6-SIV immunization was ass

10 However, a single mouse experienced breakthrough infection after 63 days when the serum HMAb

11 red in 13 patients (4%), including 1 case of breakthrough infection and 12 relapses, and was associat

12 acute seronegative HIV infection and in PrEP breakthrough infections and that FTC is associated with

13 duals and the later clinical consequences of breakthrough infection can provide insight into strategi

14 methods and tools applicable to analysis of breakthrough infection genomes in general vaccine effica

15 continued gel dosing postinfection, neither breakthrough infection had evidence of drug resistance b

16 High proportions of breakthrough infection have been observed.

17 host are consistent with clinical reports on breakthrough infection in anti-HBs-positive patients inf

18 Breakthrough infection in the 72-h group was detected at

19 Breakthrough infections in immunized subjects seem to as

20 of the first complete-genome analysis of the breakthrough infections in the RV144 trial, this work de

21 Breakthrough infections in vaccinated, healthy persons c

22 s the importance of comprehensive studies of breakthrough infections in vaccine trials to determine w

23 investigated through sieve analysis of HIV-1 breakthrough infections (infected vaccine and placebo re

24 etroviral resistance selected by PrEP during breakthrough infections is important because of the risk

25 The results suggest that 6 of 7 breakthrough infections may be related to incomplete imm

26 Although breakthrough infections occur in partially protected vac

27 ation monitoring may be required to minimize breakthrough infection or relapsing mucormycosis associa

28 Whereas none of the 16 breakthrough infections possessed vaccine-induced HIV-1-

29 Increased rates of breakthrough infection, renal scarring and surgical fail

30 Moreover, sequencing of viruses from breakthrough infections revealed selective pressure agai

31 Interestingly, RMs experiencing breakthrough infection showed significantly higher prech

32 Breakthrough infections underline the importance of earl

33 Breakthrough infections, usually after incomplete RV vac

34 Asymptomatic breakthrough infections were detected in 16 participants

35 larpGAP was completely attenuated showing no breakthrough infections while efficiently inducing high-

36 mia while receiving ganciclovir; 3 (20%) had breakthrough infection with all three methods, including

37 tudy, rhesus macaques, after vaccination and breakthrough infection with homologous simian-human immu

38 No increase in breakthrough infections with antibiotic-resistant organi

39 However, breakthrough infections with fungal pathogen Aspergillus

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。